Literature DB >> 20564647

Comparison of classification systems in melanoma sentinel lymph nodes--an analysis of 697 patients from a single center.

Andre Meier1, Imke Satzger, Bernward Völker, Alexander Kapp, Ralf Gutzmer.   

Abstract

BACKGROUND: In melanoma, different classification systems have been proposed that predict overall survival (OS) and recurrence-free survival (RFS) based on findings in the sentinel lymph node (SLN). The authors of this report compared the RFS and OS of 697 melanoma patients as predicted by various classification systems.
METHODS: The Rotterdam system (based on the greatest dimension of the largest tumor cell deposit), the Augsburg S-classification (based on tumor penetrative depth [TPD]), and the Hannover system (based on a combination of tumor load, TPD, and invasion of the capsule) were studied in 697 consecutive melanoma patients who underwent SLN biopsy at the authors' center.
RESULTS: In univariate analyses, the Rotterdam and Hannover systems (but not the S-classification) identified 1 group of SLN-positive patients that had OS and RFS similar to the OS and RFS of SLN-negative patients. The intermediate groups from all classification systems did not differ significantly with regard to RFS and/or OS from the adjacent groups. In multivariate analysis using a Cox model, the greatest dimension of the largest tumor cell deposit (cutoff point, <0.1 mm vs > or = 0.1 mm), the TPD (cutoff point, < or = 2 mm vs > 2 mm), and capsular involvement represented independent parameters for RFS; and TPD and capsular involvement also were independent parameters for OS. On the basis of these 3 parameters, a new scoring system for risk assessment in patients with melanoma is proposed that can distinguish 3 separate groups of patients that differed significantly in OS and RFS.
CONCLUSIONS: Different parameters of independent prognostic significance were identified in SLNs from patients with melanoma. Combining these parameters, the prognosis of patients with melanoma was predicted more precisely by the new scoring system than by currently published classification systems.

Entities:  

Mesh:

Year:  2010        PMID: 20564647     DOI: 10.1002/cncr.25074

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  [Malignant head and neck melanoma : Part 1: Diagnosis and histological particularities].

Authors:  C Pföhler; T Vogt; C S L Müller
Journal:  HNO       Date:  2015-07       Impact factor: 1.284

Review 2.  Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.

Authors:  Fernanda Costa Svedman; Demetris Pillas; Aliki Taylor; Moninder Kaur; Ragnar Linder; Johan Hansson
Journal:  Clin Epidemiol       Date:  2016-05-26       Impact factor: 4.790

3.  Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma.

Authors:  Cecelia E Schmalbach; Carol R Bradford
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-02-05

Review 4.  Complete lymphadenectomy following positive sentinel lymph node biopsy in cutaneous melanoma: a critical review.

Authors:  Daniel Eiger; Daniel Arcuschin de Oliveira; Renato Leão de Oliveira; Murilo Costa Sousa; Mireille Darc Cavalcante Brandão; Renato Santos de Oliveira Filho
Journal:  An Bras Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.896

5.  The sentinel node invasion level (SNIL) as a prognostic parameter in melanoma.

Authors:  Lutz Kretschmer; Christina Mitteldorf; Simin Hellriegel; Andreas Leha; Alexander Fichtner; Philipp Ströbel; Michael P Schön; Felix Bremmer
Journal:  Mod Pathol       Date:  2021-06-15       Impact factor: 7.842

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.